SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001144204-16-113769
Filing Date
2016-07-21
Accepted
2016-07-20 17:37:06
Documents
69

Document Format Files

Seq Description Document Type Size
1 S-1 v444147_s1.htm S-1 1294687
2 EXHIBIT 5.1 v444147_ex5-1.htm EX-5.1 8145
3 EXHIBIT 23.1 v444147_ex23-1.htm EX-23.1 2566
4 GRAPHIC tlogo.jpg GRAPHIC 11025
5 GRAPHIC image_001.jpg GRAPHIC 33540
  Complete submission text file 0001144204-16-113769.txt   7156406

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgrx-20160331.xml EX-101.INS 1868653
7 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20160331.xsd EX-101.SCH 55751
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20160331_cal.xml EX-101.CAL 34365
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20160331_def.xml EX-101.DEF 276310
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20160331_lab.xml EX-101.LAB 347125
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20160331_pre.xml EX-101.PRE 334132
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-212606 | Film No.: 161776166
SIC: 2834 Pharmaceutical Preparations